查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594559

肥胖治疗市场：按药物、手术、设备分类 - 全球预测 2025-2030

Obesity Treatment Market by Drugs, Surgery & Devices - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年肥胖治疗市值为171.4亿美元，预计到2024年将达到188.8亿美元，复合年增长率为10.24%，到2030年将达到339.3亿美元。

肥胖治疗包括各种帮助个人达到并维持健康体重的介入措施，包括改变生活方式、药物和手术选择。对有效肥胖治疗的需求源于全球肥胖盛行率的不断上升，肥胖带来了重大的健康风险，如糖尿病、心血管疾病和某些癌症。应用程式涵盖医疗保健提供者、健康计划和公共卫生倡议，最终用户范围从个别患者到大型医疗保健组织。该领域的市场成长主要得益于人们对肥胖相关健康问题的认识不断提高、治疗方法的进步以及政府的支持政策。主要影响因素包括医疗设备的技术创新、新药的开发以及行动医疗应用程式和远端医疗服务等数位健康解决方案的进一步整合。最近的一个潜在治疗机会在于个人化医疗方法，利用遗传见解来制定量身定制的治疗计划。然而，该行业面临治疗成本上升、监管障碍以及与肥胖相关的社会耻辱等挑战。也存在一些限制，例如某些地区获得医疗保健的机会有限以及患者对治疗的依从性不一致。最佳创新领域包括开发非侵入性治疗方法、先进的行为治疗技术以及跨部门伙伴关係以增强患者参与和结果追踪。该市场是动态的、多元化的，其特点是技术创新迅速、竞争激烈。公司必须应对监管的复杂性，并专注于具有成本效益的解决方案，以确保市场渗透。为了利用新机会，企业必须投资持续的研发，采用数位转型策略，并与公共卫生机构合作以扩大其覆盖范围和影响力。解决这些因素可以显着提高治疗效果和患者的生活质量，同时确保长期的市场成功。

主要市场统计
基准年[2023] 171.4亿美元
预测年份 [2024] 188.8亿美元
预测年份 [2030] 339.3亿美元
复合年增长率（%） 10.24%

市场动态：揭示快速发展的肥胖治疗市场的关键市场洞察

供需的动态交互作用正在改变肥胖治疗市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球肥胖人口不断增加
    • 体重管理和健身意识不断增强
    • 减重手术数量增加
  • 市场限制因素
    • 产品召回与处理成本上升
  • 市场机会
    • 减重手术设备的技术进步
    • 新型微创手术研究
  • 市场挑战
    • 与治疗药物相关的风险、併发症和副作用

波特五力：驾驭肥胖治疗市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解肥胖治疗市场的外在影响

外部宏观环境因素在塑造肥胖治疗市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解肥胖治疗市场的竞争格局

对肥胖治疗市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 定位矩阵肥胖治疗市场供应商的绩效评估

FPNV定位矩阵是评估肥胖治疗市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，规划肥胖治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对肥胖治疗市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：全面分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球肥胖盛行率
      • 体重管理和健身意识不断增强
      • 减重手术增加
    • 抑制因素
      • 产品召回和高额的处理成本
    • 机会
      • 减重手术设备的技术进步
      • 新微创减重手术的研究
    • 任务
      • 与治疗相关的风险、併发症和副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 药物肥胖治疗市场

  • 食慾抑制剂
  • 伴随药物
  • 吸收不良和饱足感药物

第七章肥胖治疗市场手术与设备

  • 可调式胃束带
  • 十二指肠转管胆胰绕道手术
  • 内视镜手术
  • 胃绕道手术手术
  • 袖状切除术

第八章北美与南美肥胖治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区肥胖治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲的肥胖治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Apollo Endosurgery, Inc.
  • Atkins Nutritionals, Inc.
  • BTL Aesthetics
  • CH Boehringer Sohn AG & Ko. KG
  • Herbalife Ltd.
  • Johnson & Johnson Services, Inc.
  • Kellogg Company
  • Medtronic PLC
  • Novo Nordisk A/S
  • NutriSystem, Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • ReShape Lifesciences, Inc.
  • Vivus, Inc.
Product Code: MRR-EC2E133E32E2

The Obesity Treatment Market was valued at USD 17.14 billion in 2023, expected to reach USD 18.88 billion in 2024, and is projected to grow at a CAGR of 10.24%, to USD 33.93 billion by 2030.

Obesity treatment encompasses a range of interventions designed to help individuals achieve and maintain a healthy weight, including lifestyle changes, pharmacotherapy, and surgical options. The necessity for effective obesity treatment arises from the growing global prevalence of obesity, which poses significant health risks such as diabetes, cardiovascular diseases, and certain cancers. The applications extend across healthcare providers, wellness programs, and public health initiatives, with end-users ranging from individual patients to large health organizations. Market growth in this sector is primarily driven by increasing awareness of obesity-related health issues, advancements in medical treatments, and supportive government policies. Key influencing factors include technological innovations in medical devices, the development of new pharmaceuticals, and the increasing integration of digital health solutions like mobile health apps and telehealth services. Recent potential opportunities lay in personalized medicine approaches, leveraging genetic insights to design tailored treatment plans. However, the industry faces challenges such as the high cost of treatments, regulatory hurdles, and societal stigma associated with obesity. Limitations include limited access to healthcare in some regions and inconsistent treatment adherence among patients. The best areas for innovation include the development of non-invasive treatment modalities, advanced behavioral therapy techniques, and cross-sector partnerships to enhance patient engagement and outcome tracking. The market is dynamic and multifaceted, characterized by rapid technological innovations and a highly competitive landscape. Companies must navigate regulatory complexities and focus on cost-effective solutions to ensure market penetration. To capitalize on emerging opportunities, businesses should invest in continuous research and development, embrace digital transformation strategies, and collaborate with public health agencies to expand their reach and impact. Addressing these factors can potentially lead to significant improvements in treatment efficacy and patient quality of life while securing long-term market success.

KEY MARKET STATISTICS
Base Year [2023] USD 17.14 billion
Estimated Year [2024] USD 18.88 billion
Forecast Year [2030] USD 33.93 billion
CAGR (%) 10.24%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Obesity Treatment Market

The Obesity Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Prevalence of obese population worldwide
    • Growing awareness regarding weight management and fitness
    • Growing number of bariatric surgeries
  • Market Restraints
    • Product recall and high cost of treatment
  • Market Opportunities
    • Technological advancements in obesity surgery devices
    • Research about new minimally invasive obesity treatment procedures
  • Market Challenges
    • Associated risks, complications and side effects of treatment therapeutics

Porter's Five Forces: A Strategic Tool for Navigating the Obesity Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Obesity Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Obesity Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Obesity Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Obesity Treatment Market

A detailed market share analysis in the Obesity Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Obesity Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Obesity Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Obesity Treatment Market

A strategic analysis of the Obesity Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Obesity Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Apollo Endosurgery, Inc., Atkins Nutritionals, Inc., BTL Aesthetics, C.H. Boehringer Sohn AG & Ko. KG, Herbalife Ltd., Johnson & Johnson Services, Inc., Kellogg Company, Medtronic PLC, Novo Nordisk A/S, NutriSystem, Inc., Olympus Corporation, Pfizer, Inc., ReShape Lifesciences, Inc., and Vivus, Inc..

Market Segmentation & Coverage

This research report categorizes the Obesity Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drugs, market is studied across Appetite Suppressants, Combination Drugs, and Malabsorption & Satiety Drugs.
  • Based on Surgery & Devices, market is studied across Adjustable Gastric Banding, Biliopancreatic Diversion With Duodenal Switch, Endoscopic Procedures, Roux-en-Y Gastric Bypass, and Sleeve Gastrectomy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of obese population worldwide
      • 5.1.1.2. Growing awareness regarding weight management and fitness
      • 5.1.1.3. Growing number of bariatric surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall and high cost of treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in obesity surgery devices
      • 5.1.3.2. Research about new minimally invasive obesity treatment procedures
    • 5.1.4. Challenges
      • 5.1.4.1. Associated risks, complications and side effects of treatment therapeutics
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Obesity Treatment Market, by Drugs

  • 6.1. Introduction
  • 6.2. Appetite Suppressants
  • 6.3. Combination Drugs
  • 6.4. Malabsorption & Satiety Drugs

7. Obesity Treatment Market, by Surgery & Devices

  • 7.1. Introduction
  • 7.2. Adjustable Gastric Banding
  • 7.3. Biliopancreatic Diversion With Duodenal Switch
  • 7.4. Endoscopic Procedures
  • 7.5. Roux-en-Y Gastric Bypass
  • 7.6. Sleeve Gastrectomy

8. Americas Obesity Treatment Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Obesity Treatment Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Obesity Treatment Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Apollo Endosurgery, Inc.
  • 3. Atkins Nutritionals, Inc.
  • 4. BTL Aesthetics
  • 5. C.H. Boehringer Sohn AG & Ko. KG
  • 6. Herbalife Ltd.
  • 7. Johnson & Johnson Services, Inc.
  • 8. Kellogg Company
  • 9. Medtronic PLC
  • 10. Novo Nordisk A/S
  • 11. NutriSystem, Inc.
  • 12. Olympus Corporation
  • 13. Pfizer, Inc.
  • 14. ReShape Lifesciences, Inc.
  • 15. Vivus, Inc.

LIST OF FIGURES

  • FIGURE 1. OBESITY TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. OBESITY TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. OBESITY TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL OBESITY TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL OBESITY TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. OBESITY TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL OBESITY TREATMENT MARKET SIZE, BY APPETITE SUPPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL OBESITY TREATMENT MARKET SIZE, BY COMBINATION DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL OBESITY TREATMENT MARKET SIZE, BY MALABSORPTION & SATIETY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ADJUSTABLE GASTRIC BANDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL OBESITY TREATMENT MARKET SIZE, BY BILIOPANCREATIC DIVERSION WITH DUODENAL SWITCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ENDOSCOPIC PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL OBESITY TREATMENT MARKET SIZE, BY ROUX-EN-Y GASTRIC BYPASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL OBESITY TREATMENT MARKET SIZE, BY SLEEVE GASTRECTOMY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES OBESITY TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA OBESITY TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY DRUGS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM OBESITY TREATMENT MARKET SIZE, BY SURGERY & DEVICES, 2018-2030 (USD MILLION)
  • TABLE 103. OBESITY TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. OBESITY TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023